These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24784023)

  • 21. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate.
    Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T
    J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
    Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
    J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys.
    Burr DB; Hirano T; Turner CH; Hotchkiss C; Brommage R; Hock JM
    J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
    Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
    Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study.
    Chavassieux P; Garnero P; Duboeuf F; Vergnaud P; Brunner-Ferber F; Delmas PD; Meunier PJ
    J Bone Miner Res; 2001 Jan; 16(1):89-96. PubMed ID: 11149494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
    Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
    Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys.
    Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J
    Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys.
    Pennypacker BL; Chen CM; Zheng H; Shih MS; Belfast M; Samadfam R; Duong LT
    J Bone Miner Res; 2014 Aug; 29(8):1847-58. PubMed ID: 24591096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
    Cho DC; Kim KT; Jeon Y; Sung JK
    Acta Neurochir (Wien); 2012 Dec; 154(12):2215-23. PubMed ID: 23053289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits.
    Pennypacker BL; Duong LT; Cusick TE; Masarachia PJ; Gentile MA; Gauthier JY; Black WC; Scott BB; Samadfam R; Smith SY; Kimmel DB
    J Bone Miner Res; 2011 Feb; 26(2):252-62. PubMed ID: 20734451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
    Fox J; Miller MA; Recker RR; Turner CH; Smith SY
    Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys.
    Jerome C; Missbach M; Gamse R
    Osteoporos Int; 2011 Dec; 22(12):3001-11. PubMed ID: 21308366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey.
    Cusick T; Chen CM; Pennypacker BL; Pickarski M; Kimmel DB; Scott BB; Duong LT
    J Bone Miner Res; 2012 Mar; 27(3):524-37. PubMed ID: 22113921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
    Balena R; Toolan BC; Shea M; Markatos A; Myers ER; Lee SC; Opas EE; Seedor JG; Klein H; Frankenfield D
    J Clin Invest; 1993 Dec; 92(6):2577-86. PubMed ID: 8254015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys.
    Ominsky MS; Boyd SK; Varela A; Jolette J; Felx M; Doyle N; Mellal N; Smith SY; Locher K; Buntich S; Pyrah I; Boyce RW
    J Bone Miner Res; 2017 Apr; 32(4):788-801. PubMed ID: 27865001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New approach for osteoporosis treatment: cathepsin K inhibitor, ONO-5334].
    Manako J
    Clin Calcium; 2011 Jan; 21(1):64-9. PubMed ID: 21187596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.